Chao Zhu

an hui medical university

H指数:17

被引数:3,324

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Computed tomography enterography-based deep learning radiomics to predict stratified healing in patients with Crohn's disease: a multicenter study

INSIGHTS INTO IMAGING

IF4.5

2024-11-150

OAAI

Prevention of postpancreatectomy hemorrhage after laparoscopic pancreaticoduodenectomy by wrapping ligamentum teres hepatis surrounding hepatic portal artery

SCIENTIFIC REPORTS

IF3.9

2024-08-070

OAAI

Predicting overall survival and prophylactic cranial irradiation benefit in small-cell lung cancer with CT-based deep learning: A retrospective multicenter study

基于CT的深度学习预测小细胞肺癌的总生存期和预防性头颅照射获益: 一项回顾性多中心研究

RADIOTHERAPY AND ONCOLOGY

IF5.3

2024-06-011

PRE

Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma

用于术前预测小 (<4厘米) 透明细胞肾细胞癌的WHO/ISUP核分级的多相CT影像组学列线图

BMC CANCER

IF3.4

2023-10-099

OAAI

CTE-Based Radiomics Models Can Identify Mucosal Healing in Patients with Crohn's Disease

ACADEMIC RADIOLOGY

IF3.9

2023-09-017

PRE

A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study

基于CT的影像组学列线图预测小细胞肺癌无进展生存期: 一项多中心队列研究

RADIOLOGIA MEDICA

IF4.8

2023-08-199

PRE

Automatic Breast Volume Scanner and B-Ultrasound-Based Radiomics Nomogram for Clinician Management of BI-RADS 4A Lesions

自动乳腺容积扫描仪和基于b超的影像组学列线图，用于临床医生管理bi-rads 4A病变

ACADEMIC RADIOLOGY

IF3.9

2023-08-018

PRE

Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients (vol 9, e14594, 2023)

HELIYON

IF3.6

2023-06-010

OAAI

Mucosal healing assessment in Crohn's disease with normalized iodine concentration from dual-energy CT enterography: comparison with endoscopy

INSIGHTS INTO IMAGING

IF4.5

2023-04-135

OAAI

Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients

HELIYON

IF3.6

2023-04-013

OAAI

Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Using Contrast-Enhanced Ultrasound-Based Deep-Learning Radiomics Model

基于超声造影的深度学习影像组学模型在肝细胞癌术前分化评估中的应用

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-02-016

OAAI

Noninvasive Evaluation of Lupus Nephritis Activity Using a Radiomics Machine Learning Model Based on Ultrasound

inflammation research

IF4.1

2023-02-018

Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-0711

OAAI

Differential Diagnosis of Type 1 and Type 2 Papillary Renal Cell Carcinoma Based on Enhanced CT Radiomics Nomogram

基于增强CT影像组学列线图的1型和2型乳头状肾细胞癌鉴别诊断疾病

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-035

OAAI

Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study Efficacy and Tolerability of 140 Milligrams Once Daily and 70 Milligrams Twice Daily

CANCER

IF5.1

2010-08-04115

OAAI

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2010-06-171.3K

OAAI

Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2010-02-0371

PREAI

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

达沙替尼治疗伊马替尼耐药或不耐受的慢性粒细胞白血病急变期患者的疗效和安全性

LEUKEMIA

IF13.4

2008-08-28168

PREAI

Chao Zhu

个人简介

教育背景

工作经历

荣誉奖项

研究方向